IP Library Granted Patent US 6,951,720
Granted Patent B2
US 6,951,720 · App. 09/882,274 · Granted Oct 4, 2005

Use of phosphorothiolate polynucleotides in ligating nucleic acids

Assignees: San Diego State University Foundation; Emerald Biostructures, Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,951,720
App. No.
09/882,274
Granted
Oct 4, 2005
Kind
B2
Abstract

The invention provides a method of nonenzymatic ligation of a nucleic acid. The method consists of contacting a polynucleotide-3′ phosphorothiolate with an acceptor polynucleotide under conditions that allow formation of a phosphodiester bond between the polynucleotide-3′ phosphorothiolate and the acceptor polynucleotide. The invention also provides methods of molecular cloning. In one embodiment, the method consists of contacting an insert comprising a polynucleotide-3′ phosphorothiolate with an acceptor vector under conditions that allow formation of a phosphodiester bond between the insert and the acceptor vector to generate a vector comprising an insert polynucleotide. The invention further provides a compound consisting of a polynucleotide-3′ phosphorothiolate and a kit containing a polynucleotide-3′ phosphorothiolate. Also provided is a method of ligating a nucleic acid using a non-sequence specific topoisomerase.

Claims (42)

1. A method of non-enzymatic ligation of a nucleic acid, comprising contacting a first polynucleotide comprising a polynucleotide-3′ phosphorothiolate with an acceptor polynucleotide under conditions that allow nucleophilic attack by a 5′—OH group of the acceptor polynucleotide on the polynucleotide-3′ phosphorothiolate to form a phosphodiester bond between said first polynucleotide, and said acceptor polynucleotide, wherein a phosphodiester bond is formed between said first polynucleotide and said acceptor polynucleotide, whereby a ligated nucleic acid product is generated.

2. The method of claim 1 , wherein said first polynucleotide comprising a polynucleotide-3′ phosphorothiolate comprises a moiety having the formula:

wherein,

X is a nucleotide;

y is a positive integer;

R1 is a nucleotide base;

R2 is a hydrogen atom or hydroxyl; and

R3 is nitrophenyl.

3. The method of claim 1 , wherein said first polynucleotide comprising a polynucleotide-3′ phosphorothiolate further comprises a duplex polynucleotide.

4. The method of claim 1 , wherein said acceptor polynucleotide further comprises a duplex polynucleotide.

5. A method of replicating a ligated nucleic acid product, comprising:

(a) contacting a first polynucleotide comprising a polynucleotide-3′ phosphorothiolate with an acceptor polynucleotide under conditions that allow nucleophilic attach by a 5′ —OH group of the acceptor polynucleotide on the polynucleotide-3′ phosphorothiolate to form a phosphodiester bond between said first polynucleotide and said acceptor polynucleotide, wherein a phosphodiester bond is formed between said first polynucleotide and said acceptor polynucleotide to generate a ligated nucleic acid product, wherein one of said first polynucleotide or said acceptor polynucleotide comprises a vector, and

(b) transducing into a host cell said ligated nucleic acid product, wherein said polynucleotide product is replicated in said host cell.

6. A method of non-enzymatic ligation of a nucleic acid, comprising:

(a) contacting a polynucleotide-3′ phosphorothiolate precursor and an activator under conditions sufficient to react said polynucleotide-3′ phosphorothiolate precursor and said activator, wherein said polynucleotide-3′ phosphorothiolate precursor reacts with said activator to produce an intermediate polynucleotide comprising a polynucleotide-3′ phosphorothiolate, and

(b) contacting said intermediate polynucleotide with an acceptor polynucleotide under conditions that allow nucleophilic attack by a 5′—OH group of the acceptor polynucleotide on said polynucleotide-3′ phosphorothiolate to form a phosphodiester bond between said intermediate polynucleotide and said acceptor polynucleotide, wherein a phosphodiester bond is formed between said intermediate polynucleotide and said acceptor polynucleotide, whereby a ligated nucleic acid product is generated.

7. The method of claim 6 , wherein said activator is iodonitrobenzene.

8. A method of ligating a vector and an insert comprising, contacting an insert comprising a polynucleotide-3′ phosphorothiolate with an acceptor vector under conditions that allow nucleophilic attack by a 5′—OH group of the acceptor vector on the polynucleotide-3′ phosphorothiolate of the insert to form a phosphodiester bond between said insert and said acceptor vector, wherein a phosphodiester bond is formed between said insert and said acceptor vector, whereby a ligated product vector comprising said insert is generated.

9. The method of claim 8 , further comprising transforming said vector comprising said insert into a host cell.

10. The method of claim 8 , wherein said polynucleotide-3′ phosphorothiolate comprises a moiety having the formula:

wherein,

X is a nucleotide;

y is a positive integer;

R1 is a nucleotide base;

R2 is a hydrogen atom or hydroxyl; and

R3 is nitrophenyl.

11. A method of ligating a vector and an insert comprising:

(a) contacting a polynucleotide-3′ phosphorothiolate precursor and iodonitrobenzene under conditions sufficient to react said polynucleotide-3′ phosphorothiolate precursor and said iodonitrobenzene, wherein said polynucleotide-3′ phosphorothiolate precursor reacts with said iodonitrobenzene to produce a polynucleotide-3′ phosphorothiolate, and

(b) contacting an insert comprising said polynucleotide-3′ phosphorothiolate with an acceptor vector under conditions that allow formation of a phosphodiester bond between said insert and said acceptor vector, wherein a phosphodiester bond is formed between said insert and said acceptor vector, whereby a ligated product vector comprising said insert is generated.

12. A method of ligating a vector and an acceptor polynucleotide comprising, contacting a vector comprising a polynucleotide-3′ phosphorothiolate with an acceptor polynucleotide, under conditions that allow nucleophilic attack by a 5′—OH group of the acceptor polynucleotide on the 3′-phosphorothiolate of the vector to form a phosphodiester bond between said vector and said acceptor polynucleotide, wherein a phosphodiester bond is formed between said vector and said acceptor polynucleotide, whereby a ligated product vector comprising said acceptor polynucleotide is generated.

13. The method of claim 1 , further comprising transforming said vector comprising said acceptor polynucleotide into a hot cell.

14. The method of claim 12 , wherein said polynucleotide-3′ phosphorothiolate comprises a moiety having the formula:

wherein,

X is a nucleotide;

y is a positive integer;

R1 is a nucleotide base;

R2 is a hydrogen atom or hydroxyl; and

R3 is nitrophenyl.

15. The method of claim 12 , wherein said vector further comprises a 3′ phosphorothiolate moiety at one or more terminal ends of said vector.

16. A method of ligating a vector and acceptor polynucleotide comprising:

(a) contacting a vector comprising a polynucleotide-3′ phosphorothiolate precursor with an activator under conditions sufficient to react said polynucleotide-3′ phosphorothiolate precursor and said activator to produce a polynucleotide-3′ phosphorothiolate, wherein said polynucleotide-3′ phosphorothiolate precursor reacts with said activator to produce a polynucleotide-3′ phosphorothiolate, and

(b) contacting said vector comprising said polynucleotide-3′ phosphorothiolate with an acceptor polynucleotide, under conditions that allow nucleophilic attack by a 5′—OH group of the acceptor polynucleotide on the polynucleotide-3′ phosphorothiolate to form a phosphodiester bond between said vector and said acceptor polynucleotide, wherein a phosphodiester bond is formed between said vector and said acceptor polynucleotide, whereby a ligated product vector comprising said acceptor polynucleotide is generated.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 22, 2011
From: SAN DIEGO STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026787/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2001
From: BURGIN, ALEX B. JR.
To: SAN DIEGO STATE UNIVERSITY FOUNDATION
Reel/Frame 012226/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2001
From: STEWART, LANCE J.
To: EMERALD BIOSTRUCTURES, INCORPORATED
Reel/Frame 012226/0940 →
Continuity (2)
Provisional Application 6029031300 · May 10, 2001
Related Publication 20030165841A1 · Sep 4, 2003